Delivery Order SPE2DX22D0010-SPE2D826FBH33
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Concerta ER 27mg tablets, valued at $1,173.82. This firm fixed-price, non-competitive delivery order is scheduled for completion by December 12, 2025, and represents a child contract under AmerisourceBergen's larger pharmaceutical supply framework. The order will be fulfilled from the company's operations in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,196.31 to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 18 mg, a prescription medication used to treat attention deficit hyperactivity disorder. This firm fixed price, non-set-aside contract was awarded on December 1, 2025, with completion scheduled for December 2, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $9,872.70 to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 27 mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by August 18, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $9,598.74 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 36 mg, a controlled-release methylphenidate medication used to treat attention-deficit/hyperactivity disorder. This competitively awarded, firm fixed-price delivery order, issued on November 5, 2025, will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility and is scheduled for completion by November 6, 2025. No small business set-aside was utilized...
- The Defense Logistics Agency awarded a delivery order valued at $9,660.91 to AmerisourceBergen Drug Corp for the supply of Concerta ER 18 mg tablets (100 count) on April 21, 2025, with completion scheduled for April 22, 2025. This is a firm fixed-price, non-competitive delivery order executed without a set-aside designation. The product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's headquarters and primary...
- The Defense Logistics Agency's Medical Supply Chain awarded a $5,190.36 delivery order to AmerisourceBergen Drug Corp for Concerta ER Tablets 36mg, a controlled-release methylphenidate medication used to treat attention-deficit/hyperactivity disorder. This firm fixed-price delivery order, issued on October 29, 2025, represents a competitive award with no set-aside designation and is scheduled for completion by October 30, 2025. The order will be fulfilled from AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $5,561.60 for 100 tablets of Concerta ER 18 mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. The award, issued on November 24, 2025, represents a firm fixed-price delivery order with an ultimate completion date of November 25, 2025. The contract utilizes no set-aside designation and was competitively awarded. AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Concerta ER 27 mg tablets (100-count) with a contract value of $6,339.04. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and scheduled for completion by September 30, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's larger...
- The Defense Logistics Agency Medical Supply Chain awarded a $21,395.38 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Concerta ER Tabs 36mg, a controlled-release methylphenidate medication used to treat attention-deficit/hyperactivity disorder. The contract is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This award was competitively awarded...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,010.89 to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 54 mg, a prescription medication used to treat attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price delivery order was issued on October 23, 2025, with an ultimate completion date of October 24, 2025, and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FBH33Delivery Order
The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $9,443.00 to AmerisourceBergen Drug Corp for the supply of Concerta ER tablets 18mg, a prescription medication commonly used to treat attention-deficit/hyperactivity disorder. This was a competitively awarded, firm fixed-price delivery order with no set-aside designation, issued on November 25, 2025, with an ultimate completion date of November 26, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that authorizes the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems globally. AmerisourceBergen is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, with extensive experience fulfilling federal requirements across multiple therapeutic domains including specialty medications, vaccines, and medical devices for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.4k | 11/24/25 |